Genito Urinary Translational Study (GUTS) Group
The goal of this forum is to promote the discussion of state-of-the-art research in genito-urinary medicine, with the goal of expanding basic, clinical, and translational research and training at MMC.
Note: The next GUTS groupmeeting is:
January 31, 2013
7am
MMC Dana Room 1
Moritz Hansen, MD:
Resident/Fellow Project Review.
New: Funding Opportunities for MMC Staff, Residents, and Fellows
Links of interest:
MaineHealth Cancer Resource Center
Maine Coalition to fight prostate cancer
Recent Interesting Studies or Reviews:
Center for Outcomes REsearch Interest: SEER-related:
Overall and Cancer-Specific Survival of Patients WithBreast, Colon, Kidney, and Lung Cancers With and Without Chronic LymphocyticLeukemia: A SEER Population-Based Study. Solomon BM, Rabe KG, Slager SL, BrewerJD, Cerhan JR, Shanafelt TD. J Clin Oncol. 2013
Is Repeat Prostate Biopsy Associated with a Greater Risk ofHospitalization? Data from SEER-Medicare. Loeb S, Carter HB, Berndt SI, RickerW, Schaeffer EM. J Urol. 2012 Oct 9. doi:pii: S0022-5347(12)05184-1.
High Impact Bench Studies:
Epigenetic Repression of miR-31 Disrupts Androgen ReceptorHomeostasis and Contributes to Prostate Cancer Progression. Lin PC, Chiu YL,Banerjee S, Park K, Mosquera JM, Giannopoulou E, Alves P, Tewari AK, GersteinMB, Beltran H, Melnick AM, Elemento O, Demichelis F, Rubin MA. Cancer Res. 2013
Stromal epigenetic dysregulation is sufficient to initiatemouse prostate cancer via paracrine Wnt signaling. Zong Y, Huang J,Sankarasharma D, Morikawa T, Fukayama M, Epstein JI, Chada KK, Witte ON. ProcNatl Acad Sci U S A. 2012 Dec 11;109(50):E3395-404. doi:10.1073/pnas.1217982109